[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CCCC":3,"stock-news-CCCC":31,"homepage-market-summary":90},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CCCC","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"C4 Therapeutics, Inc.","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.","104","Watertown, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},2.95,3.19,3.33,2.93,3.14,-0.19,-6.05,3373764.172982,20100,3.1072,5.17,1.69,2428003.2551398166,36.2,1507,{"ticker":4,"count":32,"articles":33},10,[34,40,46,52,58,63,69,75,80,85],{"title":35,"link":36,"pubDate":37,"description":38,"source":39},"C4 Therapeutics (Nasdaq:CCCC) - Stock Analysis - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiwFBVV95cUxOUnRMa3o2Q3R3MUhQSlI1eklpdU5mVDVSeXpqblZoZDdXaEZ5ZmFCZ2Z5N0tYMWVxd1BqYVNmSG1OU0FoRFdQYjI1T1lvODZ4M1d2MlYySHNvdnlMaWpIWjBXbzBBVjctd2E2aXRrY2NkVVE4WDRveWhBOGZmREd5Nkx2Z3VCT0RhUF9B?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","C4 Therapeutics (Nasdaq:CCCC) - Stock Analysis Simply Wall Street","Simply Wall Street",{"title":41,"link":42,"pubDate":43,"description":44,"source":45},"Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxPdFdGMDhPdnR4QUhuX1JLYkoxUll3SVVTXzA4ZVloMDQ2ZFBOVW9mYzBMQThrZG1lS0hSYVd4VXJ0X1pzdEdSak5VeXlxWUVQb1lyUmNBSUZKeTllVHVpdXZNRGNPckZYUEppTUMwbjJJdEFvTFJpdEZUQ0NoX2R5TlliNE1YYUhzWHlnakNpZEo3T1Rybm5qUzg2NHZVbXlVR1V6enNn?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? Yahoo Finance","Yahoo Finance",{"title":47,"link":48,"pubDate":49,"description":50,"source":51},"Director receives 4,618 shares instead of cash compensation at C4 Therapeutics (CCCC) - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxPa3NyeV9Bd051dFB5VjRGZDVqa1RCQ2JDNno4OVpHOEozT2NmZ2I1RkRNaXZVdEp2RzZwR0FCLW5PT1ZqbVpfeFhETl9qTmhFVTF1U09ZN212cTlMeFNpT0ptLXdyeDgxbVRueWtaeXBUOWk3M3p3cVBKalRXZ2V2RjBlVFZaWnM1QWlQYkNCOHQtTUV5eU5BcDZnVEV0ekk5OVF3Q0tla3dUUWd4N29hQXFWWQ?oc=5","Fri, 02 Oct 2026 20:44:08 GMT","Director receives 4,618 shares instead of cash compensation at C4 Therapeutics (CCCC) stocktitan.net","stocktitan.net",{"title":53,"link":54,"pubDate":55,"description":56,"source":57},"C4 Therapeutics Reports Phase 1 Cemsidomide Biomarker Data Showing T-Cell Activation and Advances Elranatamab Combination Trial - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8gFBVV95cUxOTHgxanplRGZLMFdNSC1lU3RaTU50M25UNlRjNVNBU0ZlNFR2T0dIWkZHSEtTTnEwNjVvRzhkdmdiZjQzV3V1UGItVkhsS29oeWkybUtmQUctSHJOejBCV2hfd092Z1BQZlRvYy1mSElranZGa1NRdXZHVUlkNXFTWVJEUlZ1RkdRSVRPTEgyNGI0NkdpekxvdDY5YVdkb29IM1FtenkzMHpqTTNoZEUwX3k3WXRYOXlSSE44UDlPMk1HdlVNM0hQeG9LTWZQUTRMRVJFUkY0NjVQTXBSZ3lEaEtIeFlfbno3WjZsaG4yZ0xWdw?oc=5","Fri, 25 Sep 2026 11:11:00 GMT","C4 Therapeutics Reports Phase 1 Cemsidomide Biomarker Data Showing T-Cell Activation and Advances Elranatamab Combination Trial Quiver Quantitative","Quiver Quantitative",{"title":59,"link":60,"pubDate":61,"description":62,"source":51},"In two patients with blood cancer, tests suggest a drug combo may keep immune cells from wearing out. - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxQanEzc1hXczk5YXRkX2UxNlFiZnpZSEl3VVg3UktxNnRqc0lsYkNhdUh4OUJIcDgybkstNDkwcWVROXJ0Q1NlUG04a1dvNUhSS29KcDhKak1jMEpwRE9DVDZwOUFja29KUEw2Q0ppSHNDSWZGZEthZzlFX09XRnhjMUlUZUJVRzc5WEZIYXMtZzNIUm51NVEwRm5CMFZxVE5pNE54TkVPSVRzb0NfN2NxMWtxbWtzbmZhRlhN?oc=5","Fri, 25 Sep 2026 11:00:00 GMT","In two patients with blood cancer, tests suggest a drug combo may keep immune cells from wearing out. stocktitan.net",{"title":64,"link":65,"pubDate":66,"description":67,"source":68},"Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026 - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxOZU9FNGx6N1ZJQXdGWmI4MkgtelVadFNfYkh5NHd3cURKS0RCS2o5OUlNcFpwTzVROGVZa1pONmpnNWM1UjhtSmwxeDBkUlV4MWtZN0kwWkxQY0hNdFJZSTdSTkVqM3VFSnhEalQwNDNlbE1vSXFpZjRTelNuajFlVjFlTVZJTlp0dDlGZTN6ZWtaZ29JZF9lNElSWWJPeXNZOXpucThjZkZ2XzNfNkFGNWZkdm9kSzlCWFE?oc=5","Fri, 02 Oct 2026 14:15:32 GMT","Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026 Seeking Alpha","Seeking Alpha",{"title":70,"link":71,"pubDate":72,"description":73,"source":74},"C4 Therapeutics Director Donna Roy Grogan Receives 4,618 Shares Instead of Cash Compensation - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxNTm96RWZUQjZIajQ0bVB3bG1sM2RSMGNxaXFvSWdheWRiN2V2anJZMU02NHJHQ0pXRmphR0s4RXQxbFZtMWhIeTJiS2x3eFJUdXpadm0zaVBUbnFxc2s1ZXk4RzNmRE5xaDVwaWpveDFDZDEtVXBncS1QZXhMbm82dXZURmUtSDZpOVZvTXpvZzNubDZaMzladWZuZnZ6ZUc3QWtpdlpXQ2JGNnF4a2VfTE1KbGRUWXVzZnU0SkMtdmR4QmVOR1lUZ0RrUEJ0WWhKeUdUeA?oc=5","Fri, 02 Oct 2026 22:32:12 GMT","C4 Therapeutics Director Donna Roy Grogan Receives 4,618 Shares Instead of Cash Compensation Kalkine Media","Kalkine Media",{"title":76,"link":77,"pubDate":78,"description":79,"source":51},"Shares replace cash pay as C4 Therapeutics (CCCC) director receives 3,662 shares. - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxQbTVpb1hGS1RuYzZQcWtNSmYybjNHQUkzSkZEMnVhYThsSmdZY21URlJGYWctSHlMby11NFItWmM5QzZYZWl1Q0NKZDhnUTRfWlphVE9lbUNHRzZ1MzN4Q2t5c2RLRnhiSndCeHcxWjlSWEhnWnB0MUY4VTRnZXlpMHZPenZneFR5anZQN0swQm9YNHZqOFJKbTlyX2ZaWnMybUhaanhnbGM5YVd4dk9MSFJyVQ?oc=5","Fri, 02 Oct 2026 20:44:21 GMT","Shares replace cash pay as C4 Therapeutics (CCCC) director receives 3,662 shares. stocktitan.net",{"title":81,"link":82,"pubDate":83,"description":84,"source":51},"C4 Therapeutics (NASDAQ: CCCC) CFO logs RSU shares, withholds stock for taxes - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxNbi1QVWFjUEc3ZWdtOFpBXy1CRVNxN1RxTHhhZlRBd05TbkU3SDVFVzF3Vk5ueTdTSVFQZVRra2RjTXNXWUpXeXJaRWFxTldXa2ZyYWh1V2w1Q0tDaWdEQzJZSDdYYTRUV3psTHktRkwtYU5IZUV6VVBuWTZiTEx3Q0xyUlRueWc0b2NyNlFGRG9qY2UyVFI0My1tRnZGc2tYM0F0NHN6SjlIT1lEZWh4bFlKOA?oc=5","Mon, 21 Sep 2026 20:26:00 GMT","C4 Therapeutics (NASDAQ: CCCC) CFO logs RSU shares, withholds stock for taxes stocktitan.net",{"title":86,"link":87,"pubDate":88,"description":89,"source":51},"C4 Therapeutics: 53% of 20 respond at trial dose - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxNM19ENDUzVTI4R1VvQVJ6QWRKeVhfa0xYZUMxS2xtR1ItdXZCbGhBSVZQQmUwR2ppUE40MzNrT3lSa1JQd0pHYk1WVUdHSDlJTWNQd3FYVlgwTEFOUHAwcF9DTU5hTXlJVjlBblk5ZXB5YnRrYnk3UnFXQTBhYTJ3XzJJWHJVZjc1YXhqNjk5US1wZDNPazBUSldGVGEtWkRTVGFaeUhlUXNsUEVo?oc=5","Fri, 25 Sep 2026 11:05:07 GMT","C4 Therapeutics: 53% of 20 respond at trial dose stocktitan.net",{"status":91,"indices":92,"watchlist":136,"sectors":158,"benchmarks":214},"success",[93,101,108,115,122,129],{"symbol":94,"name":95,"price":96,"change":97,"pct_change":98,"is_up":99,"sparkline":100,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":102,"name":103,"price":104,"change":105,"pct_change":106,"is_up":99,"sparkline":107,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":109,"name":110,"price":111,"change":112,"pct_change":113,"is_up":99,"sparkline":114,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":116,"name":117,"price":118,"change":119,"pct_change":120,"is_up":99,"sparkline":121,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":123,"name":124,"price":125,"change":126,"pct_change":127,"is_up":99,"sparkline":128,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":130,"name":131,"price":132,"change":133,"pct_change":134,"is_up":14,"sparkline":135,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[137,144,151],{"symbol":138,"name":139,"price":140,"change":141,"pct_change":142,"is_up":99,"sparkline":143,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":145,"name":146,"price":147,"change":148,"pct_change":149,"is_up":99,"sparkline":150,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":152,"name":153,"price":154,"change":155,"pct_change":156,"is_up":99,"sparkline":157,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[159,164,169,174,179,184,189,194,199,204,209],{"name":160,"etf":161,"change":162,"price":163,"is_up":99},"Technology","XLK",1.01,199.81,{"name":165,"etf":166,"change":167,"price":168,"is_up":99},"Financials","XLF",0.06,53.49,{"name":170,"etf":171,"change":172,"price":173,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":175,"etf":176,"change":177,"price":178,"is_up":99},"Consumer Cycl","XLY",1.13,110.04,{"name":180,"etf":181,"change":182,"price":183,"is_up":99},"Consumer Staples","XLP",0.25,80.53,{"name":185,"etf":186,"change":187,"price":188,"is_up":99},"Energy","XLE",0.4,62.95,{"name":190,"etf":191,"change":192,"price":193,"is_up":99},"Industrials","XLI",0.78,169.95,{"name":195,"etf":196,"change":197,"price":198,"is_up":99},"Materials","XLB",0.66,48.86,{"name":200,"etf":201,"change":202,"price":203,"is_up":99},"Real Estate","XLRE",0.32,40.81,{"name":205,"etf":206,"change":207,"price":208,"is_up":99},"Utilities","XLU",0.38,39.83,{"name":210,"etf":211,"change":212,"price":213,"is_up":99},"Comm Services","XLC",0.35,110.32,[215,220,224,228],{"ticker":216,"name":217,"price":218,"change":219,"is_up":99},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":221,"name":222,"price":223,"change":149,"is_up":99},"QQQ","Invesco QQQ Trust",749.58,{"ticker":225,"name":226,"price":227,"change":113,"is_up":99},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":229,"name":230,"price":231,"change":127,"is_up":99},"IWM","iShares Russell 2000",281.52]